Paper26927331
Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors.
Bady P and 2 others. J Mol Diagn, 2016. Cited by 105 papers, by iCite.
Cite this record
ConductScience Library. Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors. Papers, record 26927331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26927331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain Neoplasms | Major topic |
| DNA Methylation | Major topic |
| DNA Modification Methylases | Major topic |
| DNA Repair Enzymes | Major topic |
| Epigenomics | Major topic |
| Genomics | Major topic |
| Glioma | Major topic |
| Tumor Suppressor Proteins | Major topic |
| Biomarkers | |
| DNA Copy Number Variations | |
| Gene Expression | |
| Humans | |
| Promoter Regions, Genetic | |
| Reference Standards | |
| Reproducibility of Results | |
| Sensitivity and Specificity |
Source PubMed
Cited by85
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 105 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42974348 | DNA methylation in glioma: clinical biomarkers and emerging biosensor-based diagnostics. | Front Oncol | 2026 | https://conductscience.org/library/papers/42974348 | PubMed |
| 42867718 | MGMT promoter methylation as a molecular biomarker in neuro-oncology: current practices, challenges, and future directions. | J Neurooncol | 2026 | https://conductscience.org/library/papers/42867718 | PubMed |
| 42747321 | High-grade astrocytoma with piloid features: A clinical and genomic analysis of prognostic factors using a large cohort. | Neuro Oncol | 2026 | https://conductscience.org/library/papers/42747321 | PubMed |
| 42630077 | DNA Methylation Profiling in IDH-Mutant Gliomas: Biological Evolution, Molecular Grading and Clinical Implementation. | Neuropathol Appl Neurobiol | 2026 | https://conductscience.org/library/papers/42630077 | PubMed |
| 41770225 | Pediatric H3 G34-mutant diffuse hemispheric glioma: clinical, imaging and molecular prognostic factors, MGMT expression, and temozolomide response. | Acta Neuropathol | 2026 | https://conductscience.org/library/papers/41770225 | PubMed |
| 41649072 | Integrated high-resolution copy number and histomolecular analysis of diffuse hemispheric glioma, H3 G34-mutant reveals universal TP53 abnormalities. | Brain Pathol | 2026 | https://conductscience.org/library/papers/41649072 | PubMed |
| 41460180 | Distinct molecular profiles characterize the spontaneous growth rate of IDHmt low-grade astrocytomas and oligodendrogliomas. | Neuro Oncol | 2026 | https://conductscience.org/library/papers/41460180 | PubMed |
| 40779733 | Dual Immune Check Point Blockade in MGMT-Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial. | J Clin Oncol | 2025 | https://conductscience.org/library/papers/40779733 | PubMed |
| 40735274 | Molecular, histologic, and clinical characterization of methylation class pleomorphic xanthoastrocytoma: An analysis of 469 tumors. | Neurooncol Adv | 2025 | https://conductscience.org/library/papers/40735274 | PubMed |
| 40504671 | FGFR1 fusions in genomically and epigenetically bona fide glioblastoma, IDH-wildtype. | J Neuropathol Exp Neurol | 2026 | https://conductscience.org/library/papers/40504671 | PubMed |
| 40464417 | Beyond the Promoter: Total MGMT Gene Methylation Modulates Response to DNA-Alkylating Agents in Glioma. | Mol Cancer Ther | 2025 | https://conductscience.org/library/papers/40464417 | PubMed |
| 40444102 | Defining the recommended gray zone in O6-methylguanine-DNA methyltransferase promoter methylation pyrosequencing reporting: A robust, translatable method to implement new EANO guidelines. | Neurooncol Adv | 2025 | https://conductscience.org/library/papers/40444102 | PubMed |
| 40420192 | Tumour-associated macrophage infiltration differs in meningioma genotypes, and is important in tumour dynamics. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40420192 | PubMed |
| 40313597 | CEBPA-associated familial acute myeloid leukemia mimicking Werner syndrome: a case report. | Front Genet | 2025 | https://conductscience.org/library/papers/40313597 | PubMed |
| 40075518 | SNUH methylation classifier for CNS tumors. | Clin Epigenetics | 2025 | https://conductscience.org/library/papers/40075518 | PubMed |
| 40041202 | Clinical value of the MGMT promoter methylation score in IDHmt low-grade glioma for predicting benefit from temozolomide treatment. | Neurooncol Adv | 2025 | https://conductscience.org/library/papers/40041202 | PubMed |
| 39992425 | Predictive modeling with linear machine learning can estimate glioblastoma survival in months based solely on MGMT-methylation status, age and sex. | Acta Neurochir (Wien) | 2025 | https://conductscience.org/library/papers/39992425 | PubMed |
| 39902391 | cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics. | Neurooncol Adv | 2025 | https://conductscience.org/library/papers/39902391 | PubMed |
| 39901324 | Peripheral blood-derived immune cell counts as prognostic indicators and their relationship with DNA methylation subclasses in glioblastoma patients. | Brain Pathol | 2025 | https://conductscience.org/library/papers/39901324 | PubMed |
| 39881389 | Validating a clinically based MS-MLPA threshold through comparison with Sanger sequencing in glioblastoma patients. | Clin Epigenetics | 2025 | https://conductscience.org/library/papers/39881389 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| MGMT | 4255 | PubTator's text mining | https://conductscience.org/library/genes/4255 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/26927331
GET https://conductscience.org/api/papers/v1/26927331/cited_by?page=2